Alloy Therapeutics Announces $40M Series E to Scale Tech-Enabled Biotech Infrastructure
– Today, Alloy has over 200 partners with over 100 licensed therapeutic programs, including 22 in clinical development – Powered by AI integrated with real-world data and wet lab execution, Alloy delivers a faster, more capital-efficient path from idea to clinic BOSTON–(BUSINESS WIRE)–Alloy Therapeutics, Inc. (“Alloy”), a biotechnology ecosystem company powering the future of drug … [Read more…]
